Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT03489525 |
Title | MEDI2228 in Subjects With Relapsed/Refractory Multiple Myeloma (MEDI2228) |
Acronym | MEDI2228 |
Recruitment | Completed |
Gender | both |
Phase | Phase I |
Variant Requirements | No |
Sponsors | MedImmune LLC |
Indications | |
Therapies | |
Age Groups: | adult | senior |
Covered Countries | USA | GRC | ESP | AUS |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
Research Site | Phoenix | Arizona | 85054 | United States | Details | |
Research Site | Jacksonville | Florida | 32224 | United States | Details | |
Research Site | Boston | Massachusetts | 02114 | United States | Details | |
Research Site | Boston | Massachusetts | 02215 | United States | Details | |
Research Site | Detroit | Michigan | 48201 | United States | Details | |
Research Site | Rochester | Minnesota | 55905 | United States | Details | |
Research Site | Charlotte | North Carolina | 28204 | United States | Details | |
Research Site | Fairfax | Virginia | 22031 | United States | Details | |
Research Site | Melbourne | 3004 | Australia | Details | ||
Research Site | Athens | 11528 | Greece | Details | ||
Research Site | Badalona | 08916 | Spain | Details |